BCRX 8-K 2026-08-04

BIOCRYST PHARMACEUTICALS INC (BCRX) 8-K dated 2026-08-04 — accession 0001171843-26-005168. This URL is the filing, not the BCRX hub.

BIOCRYST PHARMACEUTICALS INC (BCRX) is a drug manufacturers - specialty & generic company listed on US.

BIOCRYST PHARMACEUTICALS INC filed a 8-K on 2026-08-04. Accession 0001171843-26-005168.

Cached items: 2.05. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. BCRX currently screens at market cap $1.83B.

Not investment advice. The BCRX SEC hub lists recent forms. The stock page is the research view.